Table 1.
Variable | n (%) or Mean (± SD) | |||
---|---|---|---|---|
Participants | n = 1111 | |||
Age (years) | 22.19 (± 2.42) | |||
Gender | Female = 842 (75.79%) | Male = 269 (24.21%) | ||
Health | Psychiatric disorder = 127 (11.43%) | Somatic disorder = 151 (13.59%) | Somatic and psychiatric comorbidity = 47 (4.23%) | No chronic conditions = 786 (70.75%) |
Psychopharmacotherapy | Yes = 95 (8.55%) | No = 1016 (91.45%) | ||
Year of study | I or II = 507 (45.63%) | III or IV = 422 (37.98%) | V or VI = 168 (15.12%) | Other (incl. postgraduate) = 14 (1.26%) |
Field of study | Medical = 333 (29.97%) | Technical = 296 (26.64%) | Other = 482 (43.38%) | |
GHQ somatic symptoms | 8.76 (±4.66) | |||
GHQ Anxiety and Insomnia | 11.40 (±5.40) | |||
GHQ Social Dysfunction | 11.78 (±4.50) | |||
GHQ Severe depression | 7.41 (±5.88) | |||
GHQ Total | 38.84 (±17.36) | |||
GHQ ≥ 24 | n = 855 (76.96%) | |||
GHQ < 24 | n = 256 (23.04%) |